|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/68 | (2006.01) |
| (11) | Number of the document | 3359967 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16787748.9 |
| Date of filing the European patent application | 2016-10-06 | |
| (97) | Date of publication of the European application | 2018-08-15 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/073880 |
| Date | 2016-10-06 |
| (87) | Number | WO 2017/060353 |
| Date | 2017-04-13 |
| (30) | Number | Date | Country code |
| 201562237910 P | 2015-10-06 | US |
| (72) |
SCHAFER, Peter H. , US
TROTTER, Matthew William Burnell , ES
|
| (73) |
Amgen (Europe) GmbH ,
Floor 6-8
Suurstoffi 22, 6343 Risch-Rotkreuz,
CH
|
| (54) | METHODS FOR TREATING INFLAMMATORY AND OTHER DISEASES AND THE USE OF BIOMARKERS AS PREDICTORS OF CLINICAL SENSITIVITY TO TREATMENT WITH APREMILAST |
| METHODS FOR TREATING INFLAMMATORY AND OTHER DISEASES AND THE USE OF BIOMARKERS AS PREDICTORS OF CLINICAL SENSITIVITY TO TREATMENT WITH APREMILAST |